IGTP and Ahead Therapeutics team (IMAGE)

Germans Trias i Pujol Research Institute

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Media Contact

Tamara Gutiérrez
Germans Trias i Pujol Research Institute
tgutierrez@igtp.cat
Office: 93 554 3054

Progress in developing specific immunotherapies for type 1 diabetes

Germans Trias i Pujol Research Institute

Journal: Journal of Autoimmunity
Funder: Spanish Government, MCIN/AEI/10.13039/501100011033 and European Union-NextGenerationEU/PRTR, Ahead Therapeutics SL, Health Department, Agency for Management of University and Research Grants (AGAUR) of the Catalan Government, Marie Sklodowska-Curie Actions, Generalitat de Catalunya, Patient associations Associació Ajuda A La Recerca En Diabetis (AREDI), Mi Dulce Guerrero and DiabetesCEROFoundation (Spain)
DOI: 10.1016/j.jaut.2024.103196

Keywords

/Health and medicine/Medical specialties/Immunology/Immune disorders/Autoimmune disorders/Diabetes/Type 1 diabetes
/Health and medicine/Medical specialties/Immunology/Immunotherapy
/Health and medicine/Medical specialties/Immunology/Immune cells/Phagocytes/Macrophages
/Life sciences/Cell biology/Cellular physiology/Cell morphology/Cell structure/Organelles/Vesicles/Liposomes
/Health and medicine/Medical specialties/Immunology/Immunity/Autoimmunity

Original Source

https://www.germanstrias.org/en/news/496/progress-in-developing-specific-immunotherapies-for-type-1-diabetes

facebook.com/EurekAlert
@EurekAlert
youtube.com/EurekAlert

Help / FAQ
Services
Eligibility Guidelines
Contact EurekAlert!

Terms & Conditions
DMCA
Privacy Policy
Disclaimer

IGTP and Ahead Therapeutics team (IMAGE)

Caption

Credit

Usage Restrictions

License